نتایج جستجو برای: ژن flt3

تعداد نتایج: 19081  

Journal: :Blood 2006
Soheil Meshinchi Todd A Alonzo Derek L Stirewalt Michel Zwaan Martin Zimmerman Dirk Reinhardt Gertjan J L Kaspers Nyla A Heerema Robert Gerbing Beverly J Lange Jerald P Radich

Activating mutations of the FLT3 gene occur because of an internal tandem duplication of the juxta-membrane domain (FLT3/ITD) or point mutation of the activation loop domain (FLT3/ALM). The presence of FLT3 mutations as well as the allelic ratio of FLT3/ITD (ITD-AR, mutant-wild type ratio) may have prognostic significance. FLT3 mutation status of 630 children with de novo acute myeloid leukemia...

Background: Adult T cell leukemia lymphoma (ATLL) is a rare disease, significantly linked to the infection by the human T-cell lymphotropic virus 1(HTLV-1). ATLL is typically preceded by decades of clinical latency during which infected cells accumulate selectable traits leading to a malignant transformation. Amongst all the HTLV-1 infected carriers only about 3-5% will develop ATLL. Despite th...

Journal: :Blood 2005
Chunaram Choudhary Joachim Schwäble Christian Brandts Lara Tickenbrock Bülent Sargin Thomas Kindler Thomas Fischer Wolfgang E Berdel Carsten Müller-Tidow Hubert Serve

Activating mutations of Flt3 are found in approximately one third of patients with acute myeloid leukemia (AML) and are an attractive drug target. Two classes of Flt3 mutations occur: internal tandem duplications (ITDs) in the juxtamembrane and point mutations in the tyrosine kinase domain (TKD). We and others have shown that Flt3-ITD induced aberrant signaling including strong activation of si...

Journal: :Blood 2007
Obdulio Piloto Melissa Wright Patrick Brown Kyu-Tae Kim Mark Levis Donald Small

Continuous treatment of malignancies with tyrosine kinase inhibitors (TKIs) may select for resistant clones (ie, imatinib mesylate). To study resistance to TKIs targeting FLT3, a receptor tyrosine kinase that is frequently mutated in acute myelogenous leukemia (AML), we developed resistant human cell lines through prolonged coculture with FLT3 TKIs. FLT3 TKI-resistant cell lines and primary sam...

2015
Alexa S. Green Thiago T. Maciel Marie-Anne Hospital Chae Yin Fetta Mazed Elizabeth C. Townsend Sylvain Pilorge Mireille Lambert Etienne Paubelle Arnaud Jacquel Florence Zylbersztejn Justine Decroocq Laury Poulain Pierre Sujobert Nathalie Jacque Kevin Adam Jason C. C. So Olivier Kosmider Patrick Auberger Olivier Hermine David M. Weinstock Catherine Lacombe Patrick Mayeux Gary J. Vanasse Anskar Y. Leung Ivan C. Moura Didier Bouscary Jerome Tamburini

Fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD) is frequently detected in acute myeloid leukemia (AML) patients and is associated with a dismal long-term prognosis. FLT3 tyrosine kinase inhibitors provide short-term disease control, but relapse invariably occurs within months. Pim protein kinases are oncogenic FLT3-ITD targets expressed in AML cells. We show that increased Pim...

Journal: :Croatian medical journal 2008
Hong-Ling Peng Guang-Sen Zhang Fan-Jie Gong Jian-Kai Shen Yang Zhang Yun-Xiao Xu Wen-Li Zheng Chong-Wen Dai Min-Fei Pei Jun-Jie Yang

AIM To assess the expression level of fms-like tyrosine kinase 3 (FLT3), the incidence of FLT3/internal tandem duplications (ITD) mutation, and prognostic value of FLT3 changes in different types of adult leukemia. METHODS Bone marrow mononuclear cells were isolated from 147 adult patients with leukemia. Reverse transcriptase polymerase chain reaction (PCR) was used to screen FLT3/ITD mutatio...

2017
Ellen L. Weisberg Alexandre Puissant Richard Stone Martin Sattler Sara J. Buhrlage Jing Yang Paul W. Manley Chengcheng Meng Michael Buonopane John F. Daley Suzan Lazo Renee Wright David M. Weinstock Amanda L. Christie Kimberly Stegmaier James D. Griffin

Oncogenic FLT3 kinase is a clinically validated target in acute myeloid leukemia (AML), and both multi-targeted and selective FLT3 inhibitors have been developed. Spleen tyrosine kinase (SYK) has been shown to be activated and increased in FLT3-ITD-positive AML patients, and has further been shown to be critical for transformation and maintenance of the leukemic clone in these patients. Further...

Journal: :Cancer research 2001
S P Whitman K J Archer L Feng C Baldus B Becknell B D Carlson A J Carroll K Mrózek J W Vardiman S L George J E Kolitz R A Larson C D Bloomfield M A Caligiuri

The FLT3 gene is mutated by an internal tandem duplication (ITD) in 20-25% of adults with acute myeloid leukemia (AML). We studied 82 adults <60 years of age with primary AML and normal cytogenetics, who received uniform high-dose therapy and found FLT3 ITD in 23 (28%) patients. When the 23 FLT3 ITD+ cases were compared with the 59 cases with wild-type (WT) FLT3, disease-free survival (DFS) was...

2014
D L Stirewalt E L Pogosova-Agadjanyan K Tsuchiya J Joaquin S Meshinchi

Patients with high FLT3 internal tandem duplication allelic ratios (FLT3/ITD-ARs) have a poor prognosis. Single-nucleotide polymorphism/comparative genomic hybridization, single-cell PCR and colony-forming assays were used to evaluate genotypic evolution of high FLT3/ITD-ARs in 85 acute myeloid leukemia (AML) patients. Microarrays were used to examine molecular pathways disrupted in leukemic bl...

Journal: :The Journal of Experimental Medicine 2006
Nobuyuki Onai Aya Obata-Onai Roxane Tussiwand Antonio Lanzavecchia Markus G. Manz

Flt3 ligand (Flt3L) is a nonredundant cytokine in type I interferon-producing cell (IPC) and dendritic cell (DC) development, and IPC and DC differentiation potential is confined to Flt3+ hematopoietic progenitor cells. Here, we show that overexpression of human Flt3 in Flt3- (Flt3(-)Lin(-)IL-7Ralpha(-)Thy1.1(-)c-Kit+) and Flt3+ (Flt3(+)Lin(-)IL-7Ralpha(-)Thy1.1(-)c-Kit+) hematopoietic progenit...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید